Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (9) , 1218-1225
- https://doi.org/10.1016/s0959-8049(02)00037-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathologySkeletal Radiology, 1998
- Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1998
- Predictive factors for local recurrence in osteosarcoma 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapyActa Orthopaedica, 1998
- Prognostic Factors Among 130 Patients With OsteosarcomaClinical Orthopaedics and Related Research, 1997
- Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma IntergroupThe Lancet, 1997
- Comparison of quantitative ground substance analysis in biopsy and resected tumour in osteosarcomas*Virchows Archiv, 1987
- Causes of increased survival of patients with osteosarcomaJournal of Bone and Joint Surgery, 1984
- Osteosarcoma with small cells simulating Ewingʼs tumor.Journal of Bone and Joint Surgery, 1979
- The Prognosis of Osteosarcoma: An Analytical StudyThe British Journal of Radiology, 1966
- A REVIEW AND CLASSIFICATION OF BONE SARCOMASArchives of Surgery, 1922